Gabriel NicolasContreras Martin University of Miami Miller School of MedicineUnited States

Gabriel NicolasContreras Martin
I, Gabriel Contreras, MD, MPH, earned my medical degree in 1984 from the Autonomous University of Guadalajara in Mexico. I trained in Internal medicine, nephrology, hypertension, critical care, and earned a degree as Master in Public Health between 1989 and 2003. In 1996, I joined the School of Medicine at the University of Miami. During my time as faculty in the Department of Medicine, I have been involved in the development and establishment of a successful clinical research program in the Division of Nephrology. I have an ongoing commitment to improving kidney disease outcomes among racial and ethnic minorities throughout the clinical research program at the University of Miami, Miller School of Medicine.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Precise Phenotyping and Treatment
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comSanatorio Parque SAArgentina
  • Deciphering the IGAN Cell Atlas
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
    MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
  • CART-T
    JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio
  • New Targets to Reduce the Burden of Rare Kidney Diseases
    LauraMariani Speaker University of MichiganUnited States
  • Q and A
Hall C4
11 a.m.
12 p.m.
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria
Hall A

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
Insights From Understanding Heterogeneous Trajectories to Kidney Failure
FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina
Magdalena Madero Chairperson Chief of Nephrology, Instituto Nacional de CardiolMexico
PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada
  • Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function
    JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States
  • Understanding the Heterogeneous Trajectory of CKD
    MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States
  • Review of Medical Therapies Proven to Delay CKD Progression
    DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom
  • Impact of Obesity and Novel Treatment Strategies on CKD Progression
    PeterRossing Speaker Steno Diabetes Center Copenhagen Denmark
  • Q and A
Hall C4
Hypertension - the Cutting Edge: Advances in Science and Management
TaraChang Chairperson tichang@stanford.eduStanford UniversityUnited States
Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina)
  • Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension
    GerardoGamba Speaker gamba@biomedicas.unam.mxUniversidad Nacional Autónoma de MéxicoMexico
  • Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension?
    TaliElfassy Speaker t.elfassy@med.miami.eduUnited States
  • State-of-the-Art Treatment of Hypertension in Pediatrics With CKD
    RahulChanchlani Speaker chanchlr@mcmaster.caMcMaster Children's Hospital, Hamilton, CanadaCanada
  • State-of-the-Art Treatment of Hypertension in Adults With CKD
    SusanneNicholas Speaker sunicholas@mednet.ucla.eduDavid Geffen School of Medicine at UCLAUnited States
  • Q and A
Hall D
4:30 p.m.
5:30 p.m.
Personalized Kidney Replacement Treatment: Adapting Guidelines to Real-world Scenarios
Annie-ClaireNadeau-Fredette Chairperson annieclairenaf@gmail.comUniversité de MontréalCanada
Gabriel NicolasContreras Martin Chairperson gcontrer@med.miami.eduUniversity of Miami Miller School of MedicineUnited States
Maria ElenaBiain Chairperson mariaelenabiain@yahoo.com.arMédica Nefróloga
  • The Who, What, Where, When and Why of Incremental Hemodialysis
    ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States
  • The Changing Landscape of Home Hemodialysis: Is There a Right Patient for Home Hemodialysis?
    KarthikTennankore Speaker ktennankore@gmail.comNova Scotia Health/Dalhousie UniversityCanada
  • Patient-, Center- and Country-related Risk Factors for Peritoneal Dialysis Attrition: Can We Prevent It?
    RosileneM Elias Speaker rosilenemotta@hotmail.comUniversidade de Sao PauloBrazil
  • Q and A
Hall C4

Day 3 - Tuesday April 16, 2024

Time Session
11 a.m.
12:15 p.m.
Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy)
AlessiaFornoni Chairperson United States
Prof LizLightstone Chairperson Imperial College LondonUnited Kingdom
MasaomiNangaku Chairperson mnangaku@m.u-tokyo.ac.jpJapan
  • Acceptance Speech: Bywaters Award
    MotokoYanagita Speaker Kyoto UniversityJapan
  • Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture
    EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly
  • ELP2 Graduation
    MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan
Hall A